## Discovery
- **Policy chosen:** Spain's 2022 RDL 32/2021 temporary contract ban — first causal evaluation of the largest dual labor market reform in OECD history; zero prior published evaluations
- **Ideas rejected:** Other ideas in queue were strong but this had the cleanest data access (free INE API, no auth), novel policy, and an inherently testable relabeling hypothesis
- **Data source:** INE EPA via public API — worked flawlessly, 21,600 observations across 60 quarters and 19 regions
- **Key risk:** Only 19 clusters for inference; addressed with wild bootstrap, RI, and population weighting

## Execution
- **INE API:** Straightforward JSON API. Table 3994 has different response structure than 65328 — required flexible parser. Table 306 (DIRCE firms) failed parsing entirely but was supplementary.
- **Key finding:** Total employment unaffected (β = 0.19, p = 0.52), combined with large compositional shifts in seasonal sectors — strong evidence for relabeling.
- **Critical lesson:** TempShare + PermShare ≡ 1 by construction. The "mirror coefficient" is a tautology, not evidence. The real test is the employment null + sector heterogeneity. Multiple advisor reviews flagged this — had to rewrite the paper's central argument.
- **Population weighting:** Dramatically sharpened inference (β = -0.46, p < 0.001). The reform effect is concentrated in larger regions.
- **fwildclusterboot:** Encoding issues with Spanish characters in region names — had to create numeric region IDs for bootstrap.

## Review
- **Advisor verdict:** 3 of 4 PASS (after 5 attempts). GPT R1 ✓, GPT R2 ✓, Codex-Mini ✓, Gemini ✗
- **Top criticism:** TempShare + PermShare ≡ 1 tautology was the single most impactful feedback — required restructuring Table 2, rewriting the relabeling argument, and recalibrating all mechanism claims
- **External reviews:** GPT R1 = MAJOR REVISION, GPT R2 = REJECT AND RESUBMIT, Gemini = MAJOR REVISION
- **Surprise feedback:** All three reviewers converged on the same point: null employment effect ≠ proof of relabeling. Fijo discontinuo could represent genuine improvement even without headcount changes
- **Exhibit review:** Mostly KEEP AS-IS; suggested removing redundant Appendix figures (perm share event study, robustness coefficient plot)
- **Prose review:** "Top-journal ready" — minimal changes needed
- **What changed in Stage C:** Reframed as continuous-treatment DiD; added mean reversion discussion; added region-specific trends (β=-0.250), COVID exclusion (β=-0.208), weighted bootstrap (p=0.009); toned down relabeling claims; removed drug policy analogy; acknowledged fijo discontinuo legal benefits
